Regulatory News ESMO publishes guidances on AI tools for clinicians, patients, and researchersSays one author: “We think there should be some degree of human oversight, otherwise, they can go completely rogue and nobody notices.” December 12, 2025Vol.51 No.45By Sara Willa Ernst
Conversation with The Cancer Letter Anthony Letai pledges to ensure stability for extramural and intramural cancer science December 05, 2025Vol.51 No.44By Paul Goldberg
NCI In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook December 05, 2025Vol.51 No.44By Jacquelyn Cobb
Regulatory News Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulationsBIO calls for the end of “constant turmoil,” urges the administration to “right the ship” December 05, 2025Vol.51 No.44By Paul Goldberg
Guest Editorial Mail-out colorectal cancer screening programs extend, rather than replace, clinical care December 05, 2025Vol.51 No.44By Paul J. Limburg
Sponsored Fixing site reads without burning out the readersYunu modernizes clinical trial imaging assessment workflows December 05, 2025Vol.51 No.44By Jeff Sorenson
Free Oncofertility coverage mandates expand to 21 states and DC as political momentum buildsGaps persist as patients face harrowing decisions and huge copays November 21, 2025Vol.51 No.43By Claire Marie Porter and Sara Willa Ernst
Conversation with The Cancer Letter Shane Jacobson talks about his to-do list for ACSBoost research, forge closer ties with cancer centers, launch an all-out campaign for resources November 21, 2025Vol.51 No.43
Guest Editorial My introduction to, and lessons learned from, Rick Pazdur November 21, 2025Vol.51 No.43By Mikkael A. Sekeres
FreeObituary Montefiore Einstein Director Edward Chu dies of glioblastoma at 66 November 21, 2025Vol.51 No.43By Roy S. Herbst, Mario Sznol, Vincent T. DeVita Jr., Robert L. Ferris, Nancy E. Davidson, Otis W. Brawley, Roy A. Jensen, Weijing Sun and Montefiore Einstein staff
